This grant opportunity supports research on lupus through two components: Longitudinal Studies in Population-based Cohorts of Adults with Lupus and a Pediatric Lupus Registry with Longitudinal Follow-up. The research aims to collect data on the natural history, treatment, health care access, and disparities experienced by individuals with lupus in the US. The focus includes factors such as severity, morbidity, mortality, disability, comorbidity, work interference, and more. The grant seeks to enhance understanding of lupus outcomes and improve care for both adult and pediatric populations with lupus.
Opportunity ID: 311756
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-19-003 |
| Funding Opportunity Title: | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Jan 04, 2019 |
| Last Updated Date: | Feb 27, 2019 |
| Original Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 07, 2019 |
| Estimated Total Program Funding: | $10,500,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $700,000 |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities County governments City or township governments Small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Independent school districts Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Eligibility applicants must meet the following criteria:Component A: (Longitudinal Studies of Lupus in Population-based cohorts of Adults with Lupus: 3 Year Followup):Criteria 1. Applicant must have an existing U.S. population-based cohort with > 400 adults ages 18 and greater at baseline, with SLE and/or skin lupus. Criteria 2. Applicant must have at least 4 years of followup at time of application for the four content areas listed in the Approach section above (natural history, treatment, health care access, and disparities).Component B: (A Pediatric Lupus Registry with Longitudinal Followup):Criteria 1. Applicant must have access to an existing cohort with 200+ diagnosed U.S. lupus patients ages 0-17 years at baseline in an area that is geographically population-based.If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | This NOFO is intended to support research on lupus through a 2-component cooperative agreement:Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup):This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that adults with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.Component B: (A Pediatric Lupus Registry with Longitudinal Follow up):This is a project that will support an existing US-based registry of children age 0-17 years with diagnosed lupus (SLE and skin lupus). The intent of this study is to gather baseline data for children age 0-17 years and follow up data for this cohort for three additional years. The baseline and follow up data should include these 4 content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that children with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jessie Hood
jvr4@cdc.gov Email:jvr4@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated the application package for DD/DP CIO. | Feb 27, 2019 | |
| Feb 27, 2019 | ||
| Updated this application package for this NOFO. | Feb 25, 2019 | |
| Updated the application package for this NOFO. | Jan 08, 2019 | |
| Jan 08, 2019 |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-19-003 |
| Funding Opportunity Title: | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Jan 04, 2019 |
| Last Updated Date: | Feb 27, 2019 |
| Original Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 07, 2019 |
| Estimated Total Program Funding: | $10,500,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $700,000 |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities County governments City or township governments Small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Independent school districts Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Eligibility applicants must meet the following criteria:Component A: (Longitudinal Studies of Lupus in Population-based cohorts of Adults with Lupus: 3 Year Followup):Criteria 1. Applicant must have an existing U.S. population-based cohort with > 400 adults ages 18 and greater at baseline, with SLE and/or skin lupus. Criteria 2. Applicant must have at least 4 years of followup at time of application for the four content areas listed in the Approach section above (natural history, treatment, health care access, and disparities).Component B: (A Pediatric Lupus Registry with Longitudinal Followup):Criteria 1. Applicant must have access to an existing cohort with 200+ diagnosed U.S. lupus patients ages 0-17 years at baseline in an area that is geographically population-based.If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | This NOFO is intended to support research on lupus through a 2-component cooperative agreement:Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup):This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that adults with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.Component B: (A Pediatric Lupus Registry with Longitudinal Follow up):This is a project that will support an existing US-based registry of children age 0-17 years with diagnosed lupus (SLE and skin lupus). The intent of this study is to gather baseline data for children age 0-17 years and follow up data for this cohort for three additional years. The baseline and follow up data should include these 4 content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that children with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jessie Hood
jvr4@cdc.gov Email:jvr4@cdc.gov |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-19-003 |
| Funding Opportunity Title: | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Feb 27, 2019 |
| Last Updated Date: | Feb 25, 2019 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 07, 2019 |
| Estimated Total Program Funding: | $10,500,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $700,000 |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” County governments Independent school districts For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Private institutions of higher education State governments |
| Additional Information on Eligibility: | Eligibility applicants must meet the following criteria: Component A: (Longitudinal Studies of Lupus in Population-based cohorts of Adults with Lupus: 3 Year Followup): Criteria 1. Applicant must have an existing U.S. population-based cohort with > 400 adults ages 18 and greater at baseline, with SLE and/or skin lupus. Criteria 2. Applicant must have at least 4 years of followup at time of application for the four content areas listed in the Approach section above (natural history, treatment, health care access, and disparities). Component B: (A Pediatric Lupus Registry with Longitudinal Followup): Criteria 1. Applicant must have access to an existing cohort with 200+ diagnosed U.S. lupus patients ages 0-17 years at baseline in an area that is geographically population-based. If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | This NOFO is intended to support research on lupus through a 2-component cooperative agreement: Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup): This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas: The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, and Treatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, and Component B: (A Pediatric Lupus Registry with Longitudinal Follow up): Treatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, and |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jessie Hood
jvr4@cdc.gov Email:jvr4@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-19-003 |
| Funding Opportunity Title: | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Feb 25, 2019 |
| Last Updated Date: | Jan 08, 2019 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 07, 2019 |
| Estimated Total Program Funding: | $10,500,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $700,000 |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments County governments Independent school districts Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Private institutions of higher education State governments |
| Additional Information on Eligibility: | Eligibility applicants must meet the following criteria:Component A: (Longitudinal Studies of Lupus in Population-based cohorts of Adults with Lupus: 3 Year Followup):Criteria 1. Applicant must have an existing U.S. population-based cohort with > 400 adults ages 18 and greater at baseline, with SLE and/or skin lupus. Criteria 2. Applicant must have at least 4 years of followup at time of application for the four content areas listed in the Approach section above (natural history, treatment, health care access, and disparities).Component B: (A Pediatric Lupus Registry with Longitudinal Followup):Criteria 1. Applicant must have access to an existing cohort with 200+ diagnosed U.S. lupus patients ages 0-17 years at baseline in an area that is geographically population-based.If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | This NOFO is intended to support research on lupus through a 2-component cooperative agreement:Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup):This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that adults with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.Component B: (A Pediatric Lupus Registry with Longitudinal Follow up):This is a project that will support an existing US-based registry of children age 0-17 years with diagnosed lupus (SLE and skin lupus). The intent of this study is to gather baseline data for children age 0-17 years and follow up data for this cohort for three additional years. The baseline and follow up data should include these 4 content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that children with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jessie Hood
jvr4@cdc.gov Email:jvr4@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-19-003 |
| Funding Opportunity Title: | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 08, 2019 |
| Last Updated Date: | Jan 08, 2019 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 07, 2019 |
| Estimated Total Program Funding: | $10,500,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $700,000 |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments County governments Independent school districts Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Private institutions of higher education State governments |
| Additional Information on Eligibility: | Eligibility applicants must meet the following criteria:Component A: (Longitudinal Studies of Lupus in Population-based cohorts of Adults with Lupus: 3 Year Followup):Criteria 1. Applicant must have an existing U.S. population-based cohort with > 400 adults ages 18 and greater at baseline, with SLE and/or skin lupus. Criteria 2. Applicant must have at least 4 years of followup at time of application for the four content areas listed in the Approach section above (natural history, treatment, health care access, and disparities).Component B: (A Pediatric Lupus Registry with Longitudinal Followup):Criteria 1. Applicant must have access to an existing cohort with 200+ diagnosed U.S. lupus patients ages 0-17 years at baseline in an area that is geographically population-based.If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | This NOFO is intended to support research on lupus through a 2-component cooperative agreement:Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup):This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that adults with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.Component B: (A Pediatric Lupus Registry with Longitudinal Follow up):This is a project that will support an existing US-based registry of children age 0-17 years with diagnosed lupus (SLE and skin lupus). The intent of this study is to gather baseline data for children age 0-17 years and follow up data for this cohort for three additional years. The baseline and follow up data should include these 4 content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that children with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jessie Hood
jvr4@cdc.gov Email:jvr4@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DP-19-003 |
| Funding Opportunity Title: | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.283 — Centers for Disease Control and Prevention Investigations and Technical Assistance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 08, 2019 |
| Last Updated Date: | Jan 04, 2019 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 08, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 07, 2019 |
| Estimated Total Program Funding: | $10,500,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $700,000 |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments County governments Independent school districts Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Private institutions of higher education State governments |
| Additional Information on Eligibility: | Eligibility applicants must meet the following criteria: Component A: (Longitudinal Studies of Lupus in Population-based cohorts of Adults with Lupus: 3 Year Followup): Criteria 1. Applicant must have an existing U.S. population-based cohort with > 400 adults ages 18 and greater at baseline, with SLE and/or skin lupus. Criteria 2. Applicant must have at least 4 years of followup at time of application for the four content areas listed in the Approach section above (natural history, treatment, health care access, and disparities). Component B: (A Pediatric Lupus Registry with Longitudinal Followup): Criteria 1. Applicant must have access to an existing cohort with 200+ diagnosed U.S. lupus patients ages 0-17 years at baseline in an area that is geographically population-based. If your application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | This NOFO is intended to support research on lupus through a 2-component cooperative agreement: Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup): This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas: The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, and Treatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, and Component B: (A Pediatric Lupus Registry with Longitudinal Follow up): Treatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, and |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jessie Hood
jvr4@cdc.gov Email:jvr4@cdc.gov |
Related Documents
Folder 311756 Full Announcement-FULL_ANNOUNCEMENT -> DP-19-003.pdf
Folder 311756 Revised Full Announcement-REVISED_FULL_ANNOUNCEMENT -> DP-19-003 Amendment.pdf
Packages
| Agency Contact Information: | Jessie Hood jvr4@cdc.gov Email: jvr4@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.283 | RFA-DP-19-003 | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts | PKG00247320 | Jan 04, 2019 | Mar 08, 2019 | View |
Package 1
Mandatory forms
311756 RR_SF424_2_0-2.0.pdf
311756 RR_Budget_1_4-1.4.pdf
311756 PHS398_ResearchPlan_4_0-4.0.pdf
311756 PHS398_CoverPageSupplement_4_0-4.0.pdf
311756 RR_OtherProjectInfo_1_4-1.4.pdf
311756 PerformanceSite_2_0-2.0.pdf
311756 RR_KeyPersonExpanded_2_0-2.0.pdf
Optional forms
311756 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
